Market Research Logo

US Market Report for Virtual Colonoscopy 2017 - MedCore

US Market Report for Virtual Colonoscopy 2017 - MedCore

Some of the major factors driving units down are an unfavorable reimbursement structure and strong lobbying against using colonography as one of the key colon cancer screening methods. Most of sales have occurred in the period of 2004 and 2009 when colongraphy was gaining traction. However, since 2009 the market started to rapidly decline. As of 2016, colonography is only reimbursable by CMS under certain conditions (such as failed colonoscopy), and could be reimbursed under normal conditions in 21 states. Still, the official status of virtual colonoscopy has not been established within CMS. Many private insurance companies cover colonography. Overall, the market is expected to decline at an annual mid-single digit rate. One positive factor that might help counter unit erosion is a relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States, the market might turn its attention back to colonography.

The U.S. market for virtual colonoscopy is defined in this report as virtual colonoscopy software installed on workstations and servers for CT and MRI scanners. The value of the total U.S. market for colonoscopy software decreased in 2016. The negative trend is expected throughout the forecast period and will be driven by the drop in the units sales with slightly positive addition from the ASP. The majority of virtual colonoscopy software units are sold as part of the total software package for workstations to hospitals and outpatients facilities alike. Only a small portion of units are sold as a standalone solution. For the purpose of this report the ASP was calculated based on the price of virtual colonoscopy software as part of the software bundle.


EXECUTIVE SUMMARY
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
1.1 KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
2.2.1 Gastro-Esophageal Reflux Disease (GERD)
2.2.2 Barrett's Esophagus
2.2.3 Digestive Cancer
2.2.4 Gastrointestinal bleeding
2.2.5 Bile Duct Disorders
2.2.6 Crohn’s disease
2.2.7 Ulcer
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
2.3 PATIENT DEMOGRAPHICS
2.3.11 Patient Demographics
2.3.11.1 All Digestive Diseases
2.3.11.2 Abdominal Wall Hernia
2.3.11.3 Chronic Constipation
2.3.11.4 Diverticular Disease
2.3.11.5 Prescriptions
2.3.11.6 Gastroesophageal Reflux Disease
2.3.11.7 Gastrointestinal Infections
2.3.11.8 Hemorrhoids
2.3.11.9 Inflammatory Bowel Disease
2.3.11.10 Liver Disease
2.3.11.11 Pancreatitis
2.3.11.12 Peptic Ulcer Diseases
2.3.12 Digestive Cancer
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Virtual Colonoscopy
3.1.1.1 Introduction
3.1.1.1.1 Product Matrix for Virtual Colonoscopy Market
3.2 CLINICAL TRIALS
3.2.1 Virtual Colonoscopy
3.3 PRODUCT PIPELINES
3.3.1 Boston Scientific
3.3.1.1 AXIOS™ Stent and Electrocautery Enhanced Delivery System
3.3.1.2 Acquire™ Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device
3.3.1.3 Safe Enteral Feeding Product
3.3.1.4 Rotatable Snare
3.3.2 Cook Inc.
3.3.2.1 Lehman Manometry Catheter
3.3.3 Olympus
3.3.3.1 Olympus EZ Shot 3 Plus - a single-use aspiration needle
3.3.3.2 Olympus ESG-200 Electrosurgical Generator
3.3.3.3 Retooled GI Benchmarking Service
3.3.3.4 Big Screen Surgery In 4K: VISERA 4K UHD System
3.3.3.5 TJF-Q180V Duodenoscope
3.3.3.6 From AR 2015 – new strategy plan for General Surgery Unit
3.3.4 Medtronic / Covidien
3.3.4.1 Safe Enteral Feeding Product line 2016
3.3.4.2 Barrx 360 Express RFA balloon catheter for Barrett's Esophagus
3.3.5 Avantis Medical Systems
3.3.5.1 Third Eye Panoramic Colonoscopy Device
3.3.6 Pentax Medical/ HOYA
3.3.6.1 H OPTIVISTA-EPK-i7010 Video Processor for endoscopy
3.3.7 Fujifilm
3.3.7.1 Sonart SU-1 Endoscopic Ultrasonic Processors
3.3.7.2 Double Balloon Endoscope (EN-580T)
3.3.8 US Endoscopy
3.3.8.1 Moray® micro forceps
3.3.9 CONMED Corporation
3.3.9.1 ABC D-Flex Probes
3.3.10 EndoChoice
3.3.10.1 FDA clearance for Orca™ Sterile, Single-Use Air/Water and Suction Valves
3.3.10.2 Third generation Fuse® Full Spectrum Endoscopy® System
3.3.10.3 RescueNet™ retrieval device
3.3.10.4 Lumos™ Adaptive Matrix Imaging System
3.3.11 Endogastric Solution
3.3.11.1 Next-generation version of EsophyX® Device - EsophyX® Z
3.3.12 Mederi Therapeutics
3.3.12.1 Stretta RFT3 Technology
3.3.13 C2 Therapeutics
3.3.13.1 Coldplay III Trial Validating the C2 CryoBalloon™ Focal Ablation System for treating Barret’s Esophagus
3.3.14 Medigus
3.3.14.1 Next generation MUSE™ System for the long-term treatment of GERD
3.3.15 Merit Medical Systems, Inc.
3.3.15.1 Corvocet Biopsy System
3.3.16 Medivators, Inc.
3.3.16.1 AmplifEYE™ endoscopic overtube
3.3.17 Fujifilm Medical Systems USA, Inc.
3.3.17.1 Fujifilm Diathermic Slitter (flushknife) and Fujifilm Diathermic Slitter (clutchcutter)
3.3.17.2 New additions for Double Balloon Endoscopy (DBE) platform and the Advanced Endoscopic Platform including FlushKnife and ClutchCutter
3.3.18 Cook Medical
3.3.18.1 New study “A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)”
3.3.19 Vital Images, Inc.
3.3.19.1 Vitrea CT Colon Analysis
VIRTUAL COLONOSCOPY MARKET
4.1 MARKET ANALYSIS AND FORECAST
4.2 DRIVERS AND LIMITERS
4.2.1 Market Drivers
4.2.2 Market Limiters
4.3 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016
Chart 4 1: Virtual Colonoscopy Market, U.S., 2013 – 2023
Chart 4 2: Leading Competitors, Virtual Colonoscopy Market, U.S., 2016
List of Figures
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4)
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4)
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4)
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2)
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2)
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Core Companies, Virtual Endoscope Market, U.S., 2016 (1 of 2)
Figure 3 2: Core Companies, Virtual Endoscope Market, U.S., 2016 (2 of 2)
Figure 3 3: Virtual Colonoscopy – Colonoscopy Methods for Screening Colorectal Cancer
Figure 3 4: Virtual Colonoscopy – CT-Colonography with Standard CT Scan and Optical Colonoscopy
Figure 3 5: Virtual Colonoscopy – Detection Rate of a Colorectal Cancer: CT Colonography vs. Flexible Sigmoidoscopy
Figure 4 1: Virtual Colonoscopy Market, U.S., 2013 – 2023 (US$M)
Figure 4 2: Virtual Colonoscopy Workstation Penetration Rate, U.S., 2013 – 2023 (US$M)
Figure 4 3: Drivers and Limiters, Virtual Colonoscopy Market, U.S., 2016
Figure 4 4: Leading Competitors, Virtual Colonoscopy Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report